Cargando…
Low-dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis
This clinical case demonstrates the benefits of patient treatment with low-dose naltrexone (LDN) used in erythrodermic psoriasis. A patient with a confirmed history of psoriasis by histopathology was treated with 4.5 mg of LDN during six months follow-up after an erythrodermic psoriasis flare-up. Th...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433456/ https://www.ncbi.nlm.nih.gov/pubmed/30937241 http://dx.doi.org/10.7759/cureus.3943 |